Product Description

This seminar will discuss practical strategic considerations when developing 3D printing technology for FDA-regulated products in the current regulatory environment and some tips on what to expect in the near and far future. Attendees will get an overview of applicable regulations and case studies to emphasize practical challenges and potential solutions for developing medical devices, biologics and drugs using this technology. GMP and QSR considerations for medical devices, biologics and drugs manufactured using 3D printing technology will be discussed.

Why Should you Attend:
The seminar will discuss the current available regulatory pathways to developing FDA-regulated 3D printed products and predictions on what to expect in the near future. Developers of 3D printing technology will benefit from the discussion on current available regulatory pathways for such products and what to expect in the future. 3D printing in personalized treatments will be discussed and attendees will be provided practical tips for pursuing approval with the FDA.

Objectives of the Presentation:

• 3D printing technology for medical products
• Pros and cons of 3D printing technology for medical products
• GMP and QSR considerations for 3D printing
• Non-clinical and clinical testing requirements for 3D printing technologies
• 3D printing and personalized treatments
• Recent trends in FDA involvement in 3D printed products
• Recent discussions about 3D printing and FDA-regulated products.

This *0 minutes webinar course will be held live on Thursday, July *1, *@********************

Country:	USA
Model No:	-
FOB Price:	(Negotiable) Get Latest Price
Place of Origin:	-
Price for Minimum Order:	-
Minimum Order Quantity:	-
Packaging Detail:	-
Delivery Time:	-
Supplying Ability:	-
Payment Type:	-
Product Group :	-